Loading ...
for use in transient transfections(passive) are designedCThese vectors
genescomposingtranscriptional vectors
to 1 or more(passive) is setber of vectors
for protein purification or for the isolation of proteins with an N - terminal cysteine and/or a C - terminal thioester ( 1(passive) are designedpTWIN vectors
orderto jointly designbeamforming vectors
off - target integration in the P. pastoris genome(passive) caused byintegrative vectors
by off - target integration in the P. pastoris(passive) caused byintegrative vectors
to provide an environment which allows the expression of the cloned gene after transformation into the host(passive) are especially designedVectors
of points that are used to form lines and shapes , which when combined constitute a vector(passive) are fundamentally composedVectors
of points that are used to kind lines and shapes , which when combined constitute a vector(passive) are essentially composedVectors
climate change and mutations of diseasecausingvectors
the number of these diseasecausingvectors
by the change of a small number of elements in the vectors(passive) caused byvectors
various diseasecausingvectors
alternative ecological methods against diseasecausingvectors
the major diseasecausingvectors
potential diseasecausingvectors
for a variety of applications including easy cloning of foreign DNA and easy expression of foreign proteins(passive) are designedVectors
M.L.S.designedlentiviral vectors
diseases and diseasecausingvectors
by User(passive) designed byvectors
Usercan set# of vectors
diseasecausingvectors
other diseasecausingvectors
all diseasecausingvectors
some diseasecausingvectors
Diseasecausingvectors
the diseasecausingvectors
for expression of cloned genes using known regulated promoters(passive) will be designedVectors
I use itto originatevectors
normally(passive) are ... designedNonviral vectors
often creating breeding grounds for mosquitoes and other diseasecausingvectors
insects and diseasecausingvectors
using component one alone or in combination with component two(passive) were designedVectors
of DNA(passive) are typically composedVectors
for a variety of applications including easy cloning of foreign DNA and easy expression of (passive) are designedVectors
the vector trianglecomposedof vectors
The Sub - Context influencingvectors
genetic engineering can control malariacausingvectors
the setcomposedof vectors
the problemdoes ... causethe problem
to ~680 distinct vectorsleadto ~680 distinct vectors
the commoncausethe common
of 0 and 1composedof 0 and 1
to deliver therapeutic genes into the DNA of cancer cellsare designedto deliver therapeutic genes into the DNA of cancer cells
in the decreased expression of the following gene productsresultingin the decreased expression of the following gene products
to the expression of therapeutic serum VNA levels in treated animals and protection from exposures to toxinsleadto the expression of therapeutic serum VNA levels in treated animals and protection from exposures to toxins
of several componentscomposedof several components
to segfaultscould leadto segfaults
to segfaults or buffer overflows with some sizescould leadto segfaults or buffer overflows with some sizes
to Denial of Service vectorsleadingto Denial of Service vectors
from each response variableresultingfrom each response variable
no dose limiting toxicities in humans ... and mediate an efficient mechanism of intratumoral virus spread and tumor cell killing through fusion of the infected cells to the neighboring cellscauseno dose limiting toxicities in humans ... and mediate an efficient mechanism of intratumoral virus spread and tumor cell killing through fusion of the infected cells to the neighboring cells
for gene therapydesignedfor gene therapy
specifically for the expression of the transgene in the target celldesignedspecifically for the expression of the transgene in the target cell
in 85 - 90 % cell transduction using appropriate multiplicities of infectionresultingin 85 - 90 % cell transduction using appropriate multiplicities of infection
to achieve equimolar expression of GFP and luciferasedesignedto achieve equimolar expression of GFP and luciferase
through locations called control pointsleadthrough locations called control points
for the expression of the transgene in the target celldesigned specificallyfor the expression of the transgene in the target cell
for delivery of reporter genes into target cellsdesignedfor delivery of reporter genes into target cells
for the expression of hairpin RNAs in transgenic plant cellsdesignedfor the expression of hairpin RNAs in transgenic plant cells
transmission of disease and infectionscausetransmission of disease and infections
through locations called controlleadthrough locations called control
for gene silencing in plant cellsdesignedfor gene silencing in plant cells
to possible disease transmissioncontributingto possible disease transmission
to efficient transmission of infectioncontributeto efficient transmission of infection
malaria transmissioncausingmalaria transmission
for either the transient or permanent expression of the desired genedesignedfor either the transient or permanent expression of the desired gene
to improved transgene expressionleadingto improved transgene expression
disease transmissioninfluencedisease transmission
for delivering genes and gene products into cellsdesignedfor delivering genes and gene products into cells
in a new vectorresultsin a new vector
from the vector cross productresultfrom the vector cross product
in more rapid onset of transgene expression and greater transduction efficiency in various cell types in the eyeresultin more rapid onset of transgene expression and greater transduction efficiency in various cell types in the eye
dengue , yellow fever and malariacausedengue , yellow fever and malaria
diseases such as Dengue , Zika and Chikungunyacausediseases such as Dengue , Zika and Chikungunya
for use in cancer gene therapy in vivodesignedfor use in cancer gene therapy in vivo
through Therapeutic Vector Evolutionhave been inventedthrough Therapeutic Vector Evolution
for use in cancer gene therapy in vivo as well as in vitrodesignedfor use in cancer gene therapy in vivo as well as in vitro
from fitting a four - component model to amino acid dataresultingfrom fitting a four - component model to amino acid data